Sera from nine individuals with suspected primary herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) infection were screened to identify those containing HSV type-specific immunoglobulin M (IgM). Selected sera were then utilized in an IgM-specific indirect immunofluorescent-antibody HSV-typing assay (patent pending). To evaluate the procedure, 29 HSV A variety of techniques have been used for typing herpes simplex virus (HSV) isolates, including replication in chicken embryo cells, kinetics of neutralization or endpoint neutralization tests, immunoperoxidase-or fluoresceinlabeled antibody procedures, indirect hemagglutination, solid-phase radioimmunoassay, and digestion of isolates with a restriction endonuclease (4, 5). These procedures are complicated, may require adsorption of sera to remove crossreacting antibodies, and are available only in research laboratories.
Sera from nine individuals with suspected primary herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) infection were screened to identify those containing HSV type-specific immunoglobulin M (IgM). Selected sera were then utilized in an IgM-specific indirect immunofluorescent-antibody HSV-typing assay (patent pending). To evaluate the procedure, 29 HSV isolates were grown in cultures of continuous human amnion cells, fixed, and used as substrates for indirect immunofluorescence. Determination of virus type was based on intensity of fluorescence of the substrate with HSV-1-and HSV-2-specific antisera after staining with fluorescein-conjugated anti-human IgM. Typing of the isolates by restriction endonuclease digestion showed that of 29, 18 were HSV-2 and 11 were HSV-1. Results by IgM-specific indirect immunofluorescent-antibody assay were identical to those by restriction endonuclease digestion for 27 of the isolates; 2 isolates failed to replicate adequately in the test cells. The IgM-specific indirect immunofluorescent-antibody procedure appears to be a simple, rapid, and accurate technique which could be of use to clinical virology laboratories.
A variety of techniques have been used for typing herpes simplex virus (HSV) isolates, including replication in chicken embryo cells, kinetics of neutralization or endpoint neutralization tests, immunoperoxidase-or fluoresceinlabeled antibody procedures, indirect hemagglutination, solid-phase radioimmunoassay, and digestion of isolates with a restriction endonuclease (4, 5) . These procedures are complicated, may require adsorption of sera to remove crossreacting antibodies, and are available only in research laboratories.
Human immunoglobulin from patients with recurrent skin lesions due to HSV type 1 (HSV-1) or HSV type 2 (HSV-2) reacts readily with both virus types because of common antigens (9) . In 1975, Schmidt et al. (10) reported that seven of seven patients undergoing primary HSV-1 infection and one of eight patients with primary HSV-2 disease had only type-specific HSV-neutralizing antibody in the immunoglobulin M (IgM) fraction of immunoglobulin. These observations led us to consider that individuals producing HSV-type-specific IgM could be identified and bled and a large pool of sera could be created which could be used to type HSV in an IgM-specific indirect immunofluorescent-antibody (IgM-IFA) assay. We report here our success in finding individuals with type-specific IgM rum, 100 U of penicillin per ml, and 100 Rg of gentamicin per ml, and incubated in 5% CO2 at 37°C. Phosphate-free medium, similar to the above except for the omission of inorganic phosphate and the substitution of 1% for 10% fetal calf serum, was prepared in our laboratories. At 50 to 70% confluency, the cell culture medium was changed to phosphate-free medium, and the cells were incubated for an additional 24 to 48 h. The medium was removed by aspiration, and the cells were exposed to high-titered HSV in a volume of 0.2 ml for 1 h. The virus inoculum was then removed by aspiration, and the monolayer was washed twice with phosphate-free medium. The cells were incubated in 1 ml of phosphate-free medium, and 50 to 100 ,uCi of [32P]orthophosphate (New England Nuclear Corp., Boston, Mass.) was added. When 70 to 80% cytopathic effect was apparent, the cells were frozen and thawed three times. Cell debris was pelleted by centrifugation at 1,000 x g for 10 min, and the supernatant fluid was added to a polypropylene tube (Falcon Plastics, Oxnard, Calif.) containing 2.625 ml of distilled water, 0.250 ml of a heat-treated pronase solution (20 mg/ml; Cal-Biochem, La Jolla, Calif.), and 0.125 ml of 0.4 M EDTA (Sigma Chemical Co., St. Louis, Mo.). The solution was mixed by swirling, and 1 ml of 10% sodium dodecyl sulfate (BDH Chemicals, Poole, England) was added. Nucleic acid was then extracted once with phenol and precipitated with 2 volumes of 95% ethanol. The precipitate was collected by centrifugation at 20,000 x g for 20 min and suspended in 150 1.l of distilled water containing 2 U of RNase T1 and 10 ,ug of RNase A (heat-treated; Millipore Corp., Bedford, Mass.) Acid-precipitable radioactivity was then measured in a liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.).
DNA Table 1 shows the results of IgM-IFA testing of sera from nine patients with herpetic disease, using goat anti-human gamma globulin or goat anti-human IgM and HSV-1-or HSV-2-infected AV3 cell monolayers. The patient with herpes gingivostomatitis and two of the patients with herpes genitalis had type-specific IgM class antibody against HSV. These three sera were negative when assayed for rheumatoid factor at a dilution of 1:20. Tests for HSV complementfixing antibodies were performed on the three patients with type-specific antibody, and low titers of complement-fixing antibody (8 to 32) were found in each case, although it is noteworthy that the sera tested were collected 10 to 30 days after the onset of illness, too late in the course of infection to help establish whether these cases were primary or initial herpetic disease (8) .
The results of typing 29 clinical isolates by the IgM-IFA assay, restriction endonuclease digestion, and replication in chicken embryo cells are shown in Table 2 . The results by the IgM-IFA procedure matched with the results obtained by restriction endonuclease digestion. Two isolates, both HSV-2, failed to replicate adequately in the AV3 cells used in the IgM-IFA assay. IgM-IFA correctly typed four HSV-2 isolates that grew poorly and showed high background 32p in the restriction endonuclease assay (Fig.  2) . In contrast, typing by the chicken embryo cell procedure was erroneous for one of these four isolates (HG-14), indeterminate for two others (HG-9 and HG-10), and was not performed on the fourth (HG-7).
DISCUSSION
Our results confirm the findings of Schmidt et al. (10) , showing that some persons undergoing HSV-1 or HSV-2 infection will produce only type-specific IgM against the infecting virus. We utilized the sera from two such subjects for an IgM-IFA HSV-typing assay and have shown among a small number of isolates that the IgM-IFA assay type determinations matched those obtained by restriction endonuclease digestion. Gerna et al. (2) have also successfully typed HSV isolates with human sera, employing peroxidase-labeled antiglobulin.
The type specificity of the IgM antibody re- 
